SevenOaks Biosystems Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

SevenOaks Biosystems General Information

Description

Manufacturer of surgical and medical instruments designed to offer efficient healthcare services. The company's instruments include cutting instruments, holding instruments, haemostatic forceps and re tractors, enabling clients to perform surgeries with advanced devices and ensure the safety of the patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Primary Office
  • 1 Mifflin Place
  • Suite 320
  • Cambridge, MA 02138
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SevenOaks Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2016 000 Completed Startup
1. Early Stage VC (Series A) 01-Jan-2014 000 000 000.00 Completed Startup
To view SevenOaks Biosystems’s complete valuation and funding history, request access »

SevenOaks Biosystems Executive Team (3)

Name Title Board Seat Contact Info
Sameer Sabir Chief Executive Officer & Co-Founder
Joshua Phillips Director & General Partner
Rox Anderson MD Co-Founder
To view SevenOaks Biosystems’s complete executive team members history, request access »

SevenOaks Biosystems Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Catalyst Health Ventures Venture Capital Minority 000 0000 000000 0
Hub Angels Investment Group Angel Group Minority 000 0000 000000 0
LaunchCapital Venture Capital Minority 000 0000 000000 0
Life Science Angels Angel Group Minority 000 0000 000000 0
Mass General Brigham Innovation Corporate Venture Capital Minority 000 0000 000000 0
To view SevenOaks Biosystems’s complete investors history, request access »